Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

By E. S. St Clair, D. van der Heijde, J. Smolen, R. Maini, J. Bathon, P. Emery, E. Keystone, M. Schiff, J. Kalden, Benjamin W. E. Wang and 3 more. Arthritis & Rheumatism, 2004

1,170 citations recorded by the source corpus.

Subfields: Hematology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/39a109f04dc2cfa685bdb6f317aa34788f20fb9e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Bongartz
2. A. Sutton
3. Victor M. Montori
4. Iain E. Buchan
5. M. Sweeting
6. J. Peters
7. W. Viechtbauer
8. Dan Jackson

Citations in the corpus

• Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. (2006, background): “Our findings of a significant increase in serious infections in patients treated with TNF antagonists is consistent with current knowledge of the biological actions of TNF and its role combating infections(2-4) and with findings of large observational studies and randomized controlled trials includi”